Dow Down 0.02% Nasdaq Up 0.07%

Celsion Corp. (CLSN)

-NasdaqCM
2.67 Down 0.01(0.37%) Nov 25, 4:00PM EST
Prev Close:2.68
Open:2.69
Bid:2.11 x 300
Ask:3.75 x 200
1y Target Est:7.67
Beta:1.25
Next Earnings Date:N/A
Day's Range:2.65 - 2.76
52wk Range:2.38 - 4.74
Volume:63,521
Avg Vol (3m):71,194
Market Cap:53.34M
P/E (ttm):N/A
EPS (ttm):-1.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLSN

Comparison

Symbol% ChgMkt Cap
CLSNDown 0.37%53.34M
BSDMDown 4.49%16.30M
DCTHDown 3.05%12.00M
MMSIUp 0.80%656.24M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):107.07
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.43
Quarterly EPS Est (Dec-14) :-0.37
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celsion Corporation, an oncology drug development company, focuses on the development and commercialization of chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback